Global MIS neurosurgery devices market to grow through 2025: 6 highlights

Written by Megan Wood | January 11, 2017 | Print  |

The global minimally invasive neurosurgery devices market is expected to see continued growth through 2025, based on a Future Market Insights report.

Here are five highlights:

 

1. An increasing aging population with more neurological disorders will spur market growth.

 

2. More surgeon awareness is boosting the market in developed countries.

 

3. In the Asia-Pacific countries, large populations will present market growth opportunities.

 

4. A dearth of skilled professions in developing countries as well as unfavorable reimbursements will hinder market growth, however.  

 

5. North America will continue to lead the MIS neurosurgery market because of the high volume of performed surgical procedures. Europe follows, with a large market drive due to technological advancements.

 

6. Key market players include:

 

•    Karl Storz in Tuttlingen, Germany
•    Olympus Corp. in Tokyo, Japan
•    Conmed Corp. in Utica, N.Y.
•    Richard Wolf in Vernon Hills, Ill.
•    Boston Scientific in Marlborough, Mass.
•    Integra LifeSciences in Plainsboro, N.J.
•    Aesculap Division in Center Valley, Pa.
•    Smith & Nephew in the United Kingdom
•    Medtronic in Dublin, Ireland
•    NICO Corp. in Indianapolis

 

More articles on MIS:
Interlaminar stabilization fills the spinal stenosis 'Transition Zone' — And now payment codes are catching up
SI-Bone's new warranty covers iFuse implant for 1 year after surgery: 5 key notes
Robotic-guided MIS spine surgery: Are outcomes different than fluoroscopy & freehand? 5 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months